This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Day 1 at the 2017 annual meeting of the American Society of Clinical Oncology demonstrated immunotherapy’s potential to help in treating many different types of cancers. Here are some highlights from data and learnings presented in Chicago.
ASCO17: Day 2 Immunotherapy Highlights
Read Previous Article
ASCO17: Days 4 and 5 Immunotherapy Highlights
Read Next Article
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
Cancer is not “one-size-fits-all” and neither are its treatments, especially when it comes to immunotherapy. Learn how CRI is helping more people overcome cancer.
Immunotherapy updates from the world's largest cancer conference, the Annual Meeting of the American Society for Clinical Oncology (ASCO).